ArticleFrontiers in physiology2021

Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.